We investigate how blood-forming stem cells are produced in the body, and how these stem cells drive the formation of important mature blood cells.
We are particularly passionate about understanding how platelets (the cells responsible for preventing bleeding) are made in the body and how this process can be copied in the laboratory to enable on-demand platelet production in patients.
This clinical for platelets is inadequately and precariously met through voluntary blood donations. Due to supply constraints, the use of platelets is triaged for those patients with life threatening conditions but this therapeutic should be available to all that need it. The most cutting-edge methods for platelet manufacture only yield a tiny fraction of the platelets that we know are possible. This precludes feasible laboratory-based platelet manufacture.
The Taoudi laboratory recently discovered how our bodies naturally produce platelets, this is a process we call membrane budding. By instructing megakaryocytes to undergo membrane budding in the laboratory we will be able to overcome the current scalability problem. To accomplish this we develop critical new knowledge that defines the rules of healthy platelet production in the body, and we investigate how to apply this knowledge to enable useful laboratory-based platelet production.